Identification of Genomewide Alternative Splicing Events in Sequential, Isogenic Clinical Isolates of Candida albicans Reveals a Novel Mechanism of Drug Resistance and Tolerance to Cellular Stresses
Suraya Muzafar, Ravi Datta Sharma, Abdul Haseeb Shah, Naseem A. Gaur, Ujjaini Dasgupta, Neeraj Chauhan, Rajendra Prasad
Abstract
The emergence of resistance in Candida albicans , an opportunistic pathogen, against the commonly used antifungals is becoming a major obstacle in its treatment. The necessity to identify new drug targets demands fundamental insights into the mechanisms used by this organism to develop drug resistance. C. albicans has introns in 4 to 6% of its genes, the functions of which remain largely unknown. Using the RNA-sequencing data from isogenic pairs of azole-sensitive and -resistant isolates of C. albicans , here, we show how C. albicans uses modulations in mRNA splicing to overcome antifungal drug stress.
Topics & Concepts
Candida albicansBiologyCorpus albicansOrganismAntifungal drugGeneDrug resistanceRNA splicingComputational biologyGeneticsIntronMechanism (biology)RNAFungal pathogenMicrobiologyEpistemologyPhilosophyAntifungal resistance and susceptibilityFungal Infections and StudiesRNA and protein synthesis mechanisms